ML18211A550
| ML18211A550 | |
| Person / Time | |
|---|---|
| Site: | 03019530 |
| Issue date: | 07/18/2018 |
| From: | Lanzisera P A NRC Region 1 |
| To: | Logan General Hospital, Logan Regional Medical Ctr |
| References | |
| 609177 | |
| Download: ML18211A550 (4) | |
Text
NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 4 PAGES Amendment No. 33 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee 1. Logan General Hospital, LLC d/b/a Logan Regional Medical Center 2. 20 Hospital Drive Logan, WV 25601-3474 In accordance with letter dated June 11, 2018. 4. Expiration Date: January 31, 2023 t----------------1
- 5. Docket No.: 030-19530
- 3. License number: 47-19919-01 is amended in its entirety to read as follows: Reference No.: 6. Byproduct, source, and/or special nuclear material 7. Chemical and/or physical form 8. Maximum amount that licensee 9. Authorized use may possess at any one time under this license A. Any byproduct material A. Any A. As Needed A. For use in uptake, dilution and permitted by 10 CFR excretion studies permitted by 10 CFR 35.100 35.100. B. Any byproduct material B. Any B. As Needed B. For use in imaging and localization permitted by 10 CFR studies permitted by 10 CFR 35.200. 35.200 CONDITIONS
- 10. Licensed material may be used or stored at the licensee's facilities located at 20 Hospital Drive, Logan, West Virginia.
- 11. The Radiation Safety Officer (RSO) for this license is James T. Norweck, M.S.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 2 OF 4 PAGES License Number Docket or Reference Number MATERIALS LICENSE 47-19919-01 030-19530 SUPPLEMENTARY SHEET Amendment No. 33 12. Licensed material shall only be used by, or under the supervision of: A. Individuals permitted to work as authorized users in accordance with 1 O CFR 35.13 and 1 O CFR 35.14. B. The following individuals are authorized users for the material and medical uses as indicated:
Authorized User(M.D.,0.0.,etc.}
Material and Use Mark Jason Akers, M.D. 10 CFR 35.100, 10 CFR 35.200 Paul D. Akers, M.D. 10 CFR 35.100, 10 CFR 35.200 Marsha S. Anderson, M.D. 10 CFR 35.100, 10 CFR 35.200 Rodger A. Blake, M.D. 10 CFR 35.100, 10 CFR 35.200 Paul Henry Blom, M.D. 10 CFR 35.100, 10 CFR 35.200 Peter A. Chirico, M.D. 10 CFR 35.100, 10 CFR 35.200 Ricky Jack Compton, M.D. 10 CFR 35.100,10 CFR 35.200 Jeremy Francis Cuda, M.D. 10 CFR 35.100, 10 CFR 35.200 Robert J. Cure, M.D. 10 CFR 35.100, 10 CFR 35.200 Hans G. Dransfeld, M.D. 10 CFR 35.100, 10 CFR 35.200 Joseph Dransfeld, M.D. 10 CFR 35.100,10 CFR 35.200 Joshua Dale Gibson, M.D. 1 O CFR 35.100, 10 CFR 35.200 Lee Corey Haikal, M.D. 10 CFR 35.100, 10 CFR 35.200 Nathan R. Hatfield, M.D. 10 CFR 35.100,10 CFR 35.200 Michael V. Korona, Jr., M.D. 10 CFR 35.100,10 CFR 35.200 Eric Lawrence Leonard, M.D. 10 CFR 35.100, 10 CFR 35.200 Donald Lewis, M.D. 10 CFR 35.100, 10 CFR 35.200 Kozhaya Mallah, M.D. 10 CFR 35.200 NRC FORM 374A MATERIALS LICENSE SUPPLEMENTARY SHEET Authorized User(M.D.,D.O.,etc.)
Matthew E. Maxwell, M.D. Grant Douglas Petty, M.D. James Milton Reynolds, M.D. Charles Seigler, M.D. Torin P. Walters, M.D. James Keith Watson, M.D. U.S. NUCLEAR REGULATORY COMMISSION License Number 47-19919-01 Amendment No. 33 Material and Use 10 CFR 35.100,10 CFR 35.200 10 CFR 35.100,10 CFR 35.200 10 CFR 35.100,10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100,10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 Docket or Reference Number 030-19530 PAGE 3 OF 4 PAGES 13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the minimum limit specified in 1 O CFR 30.35(d) for establishing decommissioning financial assurance.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 4 OF 4 PAGES MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 47-19919-01 Amendment No. 33 Docket or Reference Number 030-19530
- 14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accordance with the regulations.
Additionally, this license condition does not limit the licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and correspondence are more restrictive than the regulations.
A. Application dated October 2, 2012 [ML 12283A391]
B. Letter dated December 14, 2012 [ML 12353A499]
Date: July 18, 2018 FOR THE U.S. NUCLEAR REGULATORY COMMISSION By: tt~, L Penny Lanzisera Region 1